Cargando…
Potential Therapeutic Benefit of NAD(+) Supplementation for Glaucoma and Age-Related Macular Degeneration
Glaucoma and age-related macular degeneration are leading causes of irreversible blindness worldwide with significant health and societal burdens. To date, no clinical cures are available and treatments target only the manageable symptoms and risk factors (but do not remediate the underlying patholo...
Autores principales: | Cimaglia, Gloria, Votruba, Marcela, Morgan, James E., André, Helder, Williams, Pete A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551676/ https://www.ncbi.nlm.nih.gov/pubmed/32961812 http://dx.doi.org/10.3390/nu12092871 |
Ejemplares similares
-
Neuroprotection in Glaucoma: NAD(+)/NADH Redox State as a Potential Biomarker and Therapeutic Target
por: Petriti, Bledi, et al.
Publicado: (2021) -
Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
por: Dziedziak, Jacek, et al.
Publicado: (2021) -
Pharmacogenetics and nutritional supplementation in age-related macular degeneration
por: Hampton, Blake M, et al.
Publicado: (2015) -
Effects of lutein supplementation in age-related macular degeneration
por: Feng, Liwen, et al.
Publicado: (2019) -
Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
por: Nath, Madhu, et al.
Publicado: (2017)